Search - tctmd.com

Displaying 281 - 300 of 906

Sort: Relevancy | Date

News Conference News ACC 2023

Viability Testing Fails to Find HF Patients Who’d Benefit From PCI in REVIVED-BCIS2

Michael O'Riordan

March 09, 2023

News Conference News ACC 2023

Multifaceted Approach to COORDINATE Diabetes Care Improves GDMT

Yael L. Maxwell

March 07, 2023

News Conference News ACC 2023

No Downside to Immediate Complete Revascularization in ACS: BIOVASC

Michael O'Riordan

March 06, 2023

Presentation ACC 2023

A Randomized Trial Assessing The Impact Of Eliminating Copayment For High Value Preventive Medications For Low-income Seniors With Cardiovascular-related Chronic Diseases

Presenter: Braden Manns

March 06, 2023

Presentation ACC 2023

A Cluster Randomized Trial of a Personalized Clinical Decision Support Intervention to Improve Statin Prescribing in Patients With Atherosclerotic Cardiovascular Disease (PCDS Statin)

Presenter: Salim Virani

March 05, 2023

Presentation ACC 2023

A Cluster-Randomized Trial to Improve Care of Patients in Cardiology Clinics with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease [COORDINATE-Diabetes]

Presenter: Neha J. Pagidipati

March 05, 2023

News Conference News ACC 2023

Clear CVD Benefit With Bempedoic Acid: CLEAR Outcomes

Michael O'Riordan

March 04, 2023

News Daily News

Don’t Just Prescribe a Statin—Measure and Control LDL, Say NLA, ASPC

Michael O'Riordan

March 01, 2023

News Daily News

In COVID-19 Patients, Vaccination Linked to Lower MACE Risk

Michael O'Riordan

February 22, 2023

News Daily News

Longer-Term ASCVD Risk Assessment Best for Younger Patients

Michael O'Riordan

February 16, 2023

News Daily News

Only Half of Revascularized PAD Patients Receive GDMT

L.A. McKeown

February 14, 2023

News Daily News

Maternal CV Risk After Adverse Pregnancy Outcome Can Last Over 40 Years

L.A. McKeown

February 13, 2023

News Daily News

Sepsis Emerges as Powerful CVD Risk Factor in Large US Analysis

L.A. McKeown

February 02, 2023

News Daily News

UK’s NICE Recommends Lower-Risk Thresholds for Statin Therapy

Michael O'Riordan

January 20, 2023

News Daily News

PCSK9 Inhibition Shows Promise for Severe COVID-19 in Pilot Trial

Todd Neale

January 18, 2023

News Daily News

Zero CAC? LDL Cholesterol May Not Predict MI, ASCVD

Yael L. Maxwell

January 17, 2023

News Opinion CV Team Dispatch

January 2023 News Roundup

L.A. McKeown

January 16, 2023

News Daily News

Sustained LDL-Cholesterol Reductions With Inclisiran: ORION-3

Michael O'Riordan

January 16, 2023

News Daily News

CT Angiography Is Increasing in England, but Downstream Tests Are Not

Michael O'Riordan

January 12, 2023

News Daily News

Exercise Intensity, Not Volume, Linked to Atherosclerosis Progression in Men

Michael O'Riordan

January 10, 2023

Advertisement

Viability Testing Fails to Find HF Patients Who’d Benefit From PCI in REVIVED-BCIS2

Multifaceted Approach to COORDINATE Diabetes Care Improves GDMT

No Downside to Immediate Complete Revascularization in ACS: BIOVASC

A Randomized Trial Assessing The Impact Of Eliminating Copayment For High Value Preventive Medications For Low-income Seniors With Cardiovascular-related Chronic Diseases

A Cluster Randomized Trial of a Personalized Clinical Decision Support Intervention to Improve Statin Prescribing in Patients With Atherosclerotic Cardiovascular Disease (PCDS Statin)

A Cluster-Randomized Trial to Improve Care of Patients in Cardiology Clinics with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease [COORDINATE-Diabetes]

Clear CVD Benefit With Bempedoic Acid: CLEAR Outcomes

Don’t Just Prescribe a Statin—Measure and Control LDL, Say NLA, ASPC

In COVID-19 Patients, Vaccination Linked to Lower MACE Risk

Longer-Term ASCVD Risk Assessment Best for Younger Patients

Only Half of Revascularized PAD Patients Receive GDMT

Maternal CV Risk After Adverse Pregnancy Outcome Can Last Over 40 Years

Sepsis Emerges as Powerful CVD Risk Factor in Large US Analysis

UK’s NICE Recommends Lower-Risk Thresholds for Statin Therapy

PCSK9 Inhibition Shows Promise for Severe COVID-19 in Pilot Trial

Zero CAC? LDL Cholesterol May Not Predict MI, ASCVD

January 2023 News Roundup

Sustained LDL-Cholesterol Reductions With Inclisiran: ORION-3

CT Angiography Is Increasing in England, but Downstream Tests Are Not

Exercise Intensity, Not Volume, Linked to Atherosclerosis Progression in Men

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content